Scientists Create Blood Vessels, Capillaries for Lab-Grown Tissues
|
By LabMedica International staff writers Posted on 07 Feb 2011 |
Researchers have overcome one of the major hurdles on the path to growing transplantable tissue in the lab: they have found a way to grow the blood vessels and capillaries needed to keep tissues alive.
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
Latest BioResearch News
- Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer
- Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence
- Study Links Abnormal Gene Splicing to Treatment Response in Metastatic Kidney Cancer
- Research Reveals How Some Aplastic Anemia Patients Recover Bone Marrow Function
- New Molecular Insights Support Diagnosis of Hodgkin Lymphoma
- Epigenetic Signals and Blood Markers Aid Chronic Fatigue Syndrome Diagnosis
- Microenvironment Biomarkers Could Enable Early Lung Cancer Detection
- Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
- Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
- Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
- Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
- Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
- International Consensus Standardizes Tumor Microbiota Detection and Reporting
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring
Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response
Immunotherapy has transformed cancer care, yet durable benefit remains limited to a subset of patients, and clinicians still lack reliable tools to predict response before treatment begins.... Read more
Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing
Respiratory infections drive heavy testing volumes in clinical laboratories, where accurate, timely results across multiple pathogens are essential. Many labs are seeking to streamline workflows and increase... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreImmunology
view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Mpox outbreaks in non-endemic regions have underscored the need for rapid, accessible diagnostics to limit transmission. Polymerase chain reaction (PCR) remains the clinical reference, yet it depends on... Read more
T-Cell Senescence Profiling May Predict CAR T Responses
Chimeric antigen receptor (CAR) T-cell therapy can deliver striking, durable remissions, yet many patients experience minimal or no benefit. The quality of patient-derived cytotoxic T lymphocytes used... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Pancreatic cancer remains one of the hardest malignancies to treat because tumors are embedded within a dense microenvironment that shapes growth and therapy response. Standard laboratory models often... Read more
New Platform Captures Extracellular Vesicles for Early Cancer Detection
Early diagnosis remains the most effective way to reduce cancer mortality, yet many screening tools miss disease at its earliest stages. Biomarkers shed by tumors into blood and other fluids can be scarce... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more








